跳至主要内容
临床试验/NCT00198549
NCT00198549已完成4 期

Phase IV Post-Approval Evaluation of Vitrase as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Anesthetics for Ophthalmic Surgical Procedures

Bausch & Lomb Incorporated2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2004年9月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
40
试验地点
2
主要终点
To evaluate physician acceptance of efficacy of Vitrase as an adjuvant to increase absorption and dispersion of anesthetics used for ophthalmic surgical procedures

研究概览

简要总结

The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for an ophthalmic surgical procedure

排除标准

  • Known allergy to bee venom

结局指标

主要结局

To evaluate physician acceptance of efficacy of Vitrase as an adjuvant to increase absorption and dispersion of anesthetics used for ophthalmic surgical procedures

次要结局

  • To determine physician usage of and satisfaction with Vitrase in the 6200 USP unit vial

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验